Bing Zhao

7.9k total citations · 2 hit papers
169 papers, 3.5k citations indexed

About

Bing Zhao is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Bing Zhao has authored 169 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 58 papers in Epidemiology and 51 papers in Molecular Biology. Recurrent topics in Bing Zhao's work include Tuberculosis Research and Epidemiology (53 papers), Mycobacterium research and diagnosis (49 papers) and Cancer Cells and Metastasis (13 papers). Bing Zhao is often cited by papers focused on Tuberculosis Research and Epidemiology (53 papers), Mycobacterium research and diagnosis (49 papers) and Cancer Cells and Metastasis (13 papers). Bing Zhao collaborates with scholars based in China, United States and Netherlands. Bing Zhao's co-authors include Yanlin Zhao, Hui Xia, Shengfen Wang, Ye‐Guang Chen, Xichao Ou, Yuanyuan Song, Yang Zhou, Guanglu Jiang, Qiang Li and Daniel P. Chin and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Bing Zhao

154 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Survey of Drug-Resistant Tuberculosis in China

2012 491 citations Yanlin Zhao, Shengfen Wang et al. profile →
Diabetic neuropathy: cutting-edge research and future directions

2025 26 citations Bing Zhao et al. profile →

Peers

Bing Zhao

EPIDE

SURGE

ONCOL

Fei Xiao China

Youhua Xie China

Hong Zhao China

Pisit Tangkijvanich Thailand

Michael Schümann Germany

Collet Dandara South Africa

Yi‐Ming Arthur Chen Taiwan

Helen Collins United States

Yaping Chen China

Fei Xiao China

Bing Zhao

897 ×0.7

624 ×0.5

EPIDE

1.4k ×1.1

190 ×0.3

SURGE

285 ×0.7

ONCOL

Citations per year, relative to Bing Zhao Bing Zhao (= 1×) peers Fei Xiao

Countries citing papers authored by Bing Zhao

Since Specialization

Citations

This map shows the geographic impact of Bing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhao more than expected).

Fields of papers citing papers by Bing Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhao. The network helps show where Bing Zhao may publish in the future.

Co-authorship network of co-authors of Bing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Zhao. A scholar is included among the top collaborators of Bing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Zhao. Bing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Hui, et al.. (2025). Whole-process 3D ECM-encapsulated organoid-based automated high-throughput screening platform accelerates drug discovery for rare diseases. PubMed. 4(5). lnaf021–lnaf021. 2 indexed citations

Zhao, Bing, et al.. (2025). Rational design and identification of potent imidazole-fused Autotaxin inhibitors for treatment of idiopathic pulmonary fibrosis. European Journal of Medicinal Chemistry. 298. 118011–118011.

Zhao, Bing, et al.. (2025). Development of Tricyclic 4,5-Dihydro-3H-pyrrolo[2,3-c]quinolin-4-ones as Potent Autotaxin Inhibitors for Pulmonary Fibrosis Treatment In Vivo. Journal of Medicinal Chemistry. 68(7). 7476–7498. 2 indexed citations

Zhao, Bing, et al.. (2025). Development and Evaluation of a Nomogram for Predicting Pulmonary Embolism in Children With Severe Mycoplasma pneumoniae Pneumonia. Pediatric Pulmonology. 60(3). e71046–e71046.

Wang, Jiawen, et al.. (2025). Manipulation of Wnt/β‐Catenin Signaling by Synthetic Frizzled Agonist and LRP Antagonist in Organoid Cultures and In Vivo. Small Methods. 10(2). e2500425–e2500425.

Zhao, Bing, Wei Wang, Ying Liang, et al.. (2025). 2128P Total neoadjuvant chemotherapy plus PD-1 antibody in locally advanced gastric or gastro-esophageal junction adenocarcinoma: A proof-of-concept, phase II trial. Annals of Oncology. 36. S1117–S1117.

Zhao, Bing, Xin Ge, Peijun Du, et al.. (2025). CREM-activated LTBP1 transcription promotes radioresistance and immune escape in triple-negative breast cancer. Biochemical Pharmacology. 241. 117172–117172.

Zuo, Zhongyuan, Song Li, Xiao Han, et al.. (2025). SERS nanotags for ultrasensitive and dual biomarker detection of breast cancer. Sensors and Actuators Reports. 9. 100344–100344. 1 indexed citations

Zhao, Bing, et al.. (2024). Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment. European Journal of Medicinal Chemistry. 277. 116785–116785. 11 indexed citations

10.

Shen, Zhiyuan, Wei Zhu, Lin Lin, et al.. (2024). PL‐Relief^TMplus Alleviates Atopic Dermatitis and Regulates Inflammatory Responses via Inhibiting NF‐κB Signaling Pathway. Chemistry & Biodiversity. 21(8). e202400349–e202400349. 1 indexed citations

11.

Li, Sen, et al.. (2024). Discovery of Novel 4,5,6,7-Tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one Derivatives as Orally Efficacious ATX Allosteric Inhibitors for the Treatment of Pulmonary Fibrosis. Journal of Medicinal Chemistry. 68(1). 792–818. 3 indexed citations

12.

Lü, Jinhui, Bing Zhao, Qiong Wang, et al.. (2023). Identification of a SARS-CoV-2 virus-derived vmiRNA in COVID-19 patients holding potential as a diagnostic biomarker. Frontiers in Cellular and Infection Microbiology. 13. 1190870–1190870. 6 indexed citations

13.

Zhao, Yuanyuan, Bing Zhao, Gang Chen, et al.. (2022). Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin. Cancer Communications. 43(2). 246–256. 4 indexed citations

14.

Xia, Hui, Yuanyuan Song, Zheng Yang, et al.. (2022). Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing. Dove Medical Press (Taylor and Francis Group). 12 indexed citations

15.

Ma, Liyun, Jianghong Yu, Bing Zhao, et al.. (2022). Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets. Stem Cell Reviews and Reports. 18(7). 2296–2314. 8 indexed citations

16.

Liang, Jianqing, Jun Qian, Li Yang, et al.. (2022). Modeling Human Thyroid Development by Fetal Tissue‐Derived Organoid Culture. Advanced Science. 9(9). e2105568–e2105568. 25 indexed citations

17.

Zhao, Bing, Ya‐Nan Ou, Ya‐Hui Ma, et al.. (2021). Risk of seizures and subclinical epileptiform activity in patients with dementia: A systematic review and meta-analysis. Ageing Research Reviews. 72. 101478–101478. 13 indexed citations

18.

Jiang, Ning, Yamei Jiang, Qiuping He, et al.. (2020). Chromatin remodeler Znhit1 preserves hematopoietic stem cell quiescence by determining the accessibility of distal enhancers. Leukemia. 34(12). 3348–3358. 21 indexed citations

19.

Fan, Jia, et al.. (2018). Genetic Diversity and Drug Susceptibility of Mycobacterium tuberculosis Isolates in a Remote Mountain Area of China.. PubMed. 31(5). 351–362. 5 indexed citations

20.

Ou, Xichao, Yuanyuan Song, Bing Zhao, et al.. (2014). A multicenter study of Cross-Priming Amplification for tuberculosis diagnosis at peripheral level in China. Tuberculosis. 94(4). 428–433. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact